Sleeping with the enemy? A randomized conrolled trial of a collalborative health authority/industry intervention to influence prescribing practice

British Journal of Clinical Pharmacology

Volumn 49, Issue 2, 2000, Pages 174-179

  Freemantle, Nick ^e   Johnson, Richard ^a   Dennis, Jane ^b   Kennedy, Andrew ^c   Marchment, Mike ^d  

^a Warwickshire Health Authority   (United Kingdom)

^b PFIZER INC   (United States)

^c Croft Medical Centre   (United Kingdom)

^d Formerly Southern Derbyshire Health Authority   (United Kingdom)

^e UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Outreach visits; Pharmaceutical industry health authority collaboration; Prescribing practice; Randomized evaluation

Indexed keywords

PROTON PUMP INHIBITOR;

ARTICLE; AUTHORITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG COST; DRUG INDUSTRY; GENERAL PRACTICE; HEALTH SERVICE; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

DRUG INDUSTRY; FAMILY PRACTICE; HUMANS; INTERPROFESSIONAL RELATIONS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; PROGRAM EVALUATION;

EID: 0033983392     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00126.x     Document Type: Article

References (16)

1. 1 Effective Health Care. Implementing Clinical Practice Guidelines Bulletin No 8. Leeds: University of Leeds, 1994.
2. 2 Freemantle N, Mason JM, Watt I. Evidence into practice? Prescribing selective serotonin reuptake inhibitors. Int J Technol Assessment Health Care 1998; 14: 387-301.
3. 3 Eccles M, Freemantle N, Mason JM. for the North of England Evidence Based Guideline Development Project. Evidence based clinical practice guideline: angiotensin converting-inhibitors in the primary care management of adults with symptomatic heart failure. Br Med J 1998; 316: 1369-1375.
4. 4 Maynard A, Bloor K. Managed Care: Panacea or palliation? Nuffield Occasional Papers Health Economics Series: Paper No 8 London: Nuffield Trust, 1998.
5. 5 Liddell A. Commercial approaches to the NHS regarding disease management packages. EL (94), 94 Leeds: NHS Executive, 1994.
6. 6 MAAG. Steps to Better Practice? Warwick: Multi-disciplinary Audit Advisory Group, 1998.
7. 7 Wood J, Freemantle N. Choosing an appropriate unit of analysis in trials of interventions that attempt to influence practice. Journal of Health Services Research and Policy, 1999; 4: 44-88.
8. 8 Baker RJ, Nelder JA. The GLIM System Release 3 General Linear Interactive Modelling Manual. London: Royal Statistical Society, 1978.
9. 9 Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statist Sci 1986; 1: 54-77.
10. 10 Freemantle N, Wood J, Crawford F. Evidence into practice, experimentation and quasi experimentation: are the methods up to the task? J Epidemiol Community Health 1998; 52: 75-81.
11. 11 Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision-making. JAMA 1990; 263: 549-556.
12. 12 Freemantle N, Eccles M, Wood J, et al. A randomised trial of Evidence Based OutReach (EBOR): rationale and design. Controlled Clinical Trial 1999; 20: 479-492.
13. 13 Schaffner W, Ray WA, Federspiel C, et al. Improving antibiotic prescribing in office practice: a controlled trial of three educational methods. JAMA 1983; 250: 1728-1732.
14. 14 Pippalla RS, Riley DA, Chin Burapa V. Influencing the prescribing behaviour of physicians: a meta evaluation. J Pharmac Ther 1995; 20: 189-198.
15. 15 Friis H, Bro F, Mabeck CE, et al. Changes in prescription of antibiotics in general practice in relation to different strategies for drug information. Dan Med Bull 1991; 38: 380-332.
16. 16 Department of Health. The New NHS Modern - Dependable Leeds: Department of Health, Cmnd 3807; 1997.